• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (SH) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (SH) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problems Backflow (1064); Obstruction of Flow (2423); Biocompatibility (2886); Material Split, Cut or Torn (4008)
Patient Problems Aortic Valve Stenosis (1717); Dyspnea (1816); Dizziness (2194); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 04/13/2021
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2015, a 21mm trifecta valve was implanted.Follow-ups were performed once a year post-implant with no reported issues until (b)(6) 2020.In (b)(6) 2021, the patient experienced heart failure symptoms, including dyspnea and dizziness, and was diagnosed with aortic stenosis and aortic regurgitation.On (b)(6) 2021, re-do aortic valve replacement (avr) was performed and the trifecta valve was explanted.Upon explant, tears were confirmed on the right coronary cusp (rcc) - non-coronary cusp (ncc) and the left coronary cusp (lcc) - rcc.Additionally, pannus formation was observed on the inflow side of the trifecta valve.A new competitor's 25mm inspiris resilia aortic valve (manufacturer: edwards lifesciences) was successfully implanted.The patient was reported to be in stable condition.
 
Manufacturer Narrative
Additional information sections: d9, h6, h10 explant was reported due to heart failure symptoms.The investigation found that all three leaflets were torn.Leaflets 1 and 3 contained a fold/ leaflet 1 was fibrously thickened.There was circumferential fibrous pannus ingrowth on the inflow surface which narrowed the inflow diameter and extended onto the bases of all three leaflets.No acute inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.In the absence of any calcification or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, histological evaluation did demonstrate loss of collagen at the tear site, which could have contributed to the formation of the tear.In addition, the fibrous pannus ingrowth noted had the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (SH)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key11732161
MDR Text Key247591134
Report Number3008452825-2021-00241
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052023
UDI-Public05414734052023
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/10/2016
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot Number4734776
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/05/2021
Was the Report Sent to FDA? No
Date Manufacturer Received06/07/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
Patient Weight55
-
-